Hai Qing Hua
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Currently, Hai Qing Hua is Executive Director at Duality Biotherapeutics, Inc. since 2026.
Formerly, Dr. Hua was Head-Biopharmaceuticals at Hansoh Pharmaceutical Group Co., Ltd. Education includes a doctorate from the University of Zurich in 2009, an undergraduate degree from Tsinghua University in 2003, and a doctorate from Columbia University Irving Medical Center.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| DUALITY BIOTHERAPEUTICS, INC. | Directeur/Bestuurslid | 23-03-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| HANSOH PHARMACEUTICAL GROUP COMPANY LIMITED | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tsinghua University
Tsinghua University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Columbia University Medical Center
Columbia University Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hansoh Pharmaceutical Group Co., Ltd.
Hansoh Pharmaceutical Group Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and sells & develops pharmaceutical products | Health Technology |
Duality Biotherapeutics, Inc.
Duality Biotherapeutics, Inc. BiotechnologyHealth Technology Develops antibody-drug conjugate and therapeutics for cancer & autoimmune diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau